Dublin, Nov. 7, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/vn382p/patient)
has announced the addition of the "Patient
Self-Monitoring: Devices, Markets, Players and Prospects"
report to their offering.
The ability of patients to monitor their own serum levels is deemed
to be a critical tool in reducing the pathological effects of
poorly controlled disease factors. For conditions other than
diabetes, the vast majority of monitoring has until recently been
performed in physician offices or similar healthcare
settings.
The convergence of new measurement technologies, patient
demographics and managed care cost initiatives is driving patient
monitoring for a number of conditions from caregiver facilities
and into homes. In the process, patient self-monitoring for
cholesterol, INR and hypertension have the potential to transition
from a cottage industry into a significant market. The key enabler
of this significant shift will be technological advances that will
provide accurate readings in a format that consumers can
understand, clearly indicating when a follow-up visit to a
caregiver is needed. Systems that allow patients to share readings
with physicians electronically have already been introduced.
Ultimately, the success of this self-test market will rely on
monitors that can provide accurate values for the various analytes
that are associated with health risk, presenting them to the
patient in the proper context.
Highlights
- Analyzes and evaluates self-test monitoring technologies and
products, and assesses the market potential, commercialization
risks and opportunities
- Examines next-generation monitor technologies, design issues and
evolving market factors
- Provides forecasts and market data for self-monitoring products
to 2018
- Assesses the impact and influence of self-monitoring enhancements
on the healthcare management market
- Profiles self-monitoring market participants, their technology,
product development activity, and business strategies
Key Topics Covered
Disease Management Market Dynamics
- Patient Monitoring Overview
- Key Factors in Patient Compliance
- Market Drivers
- Shifting Patient Demographics
- Industry Alignment and Competitive Landscape
Self-Monitoring Technology Strategies
- Needle-Stick Tests
- Self-Collected / Mail-in Tests
- Combination Meters
- Continuous Monitors
- Future Developments
- Noninvasive Monitors
- Signal Processing Advances
Monitor Product Design & Patient Issues
- Reliability
- Measurement Frequency
- Patient/User Interface
- Measurement Electronics
- Calibration
- Accuracy/Precision
- Sensitivity
- Sensor Technology
Self-Monitoring Therapeutic Segments
- Atherosclerosis/Heart Disease (Cholesterol)
- Diabetes (Glucose)
- Heart Valve Replacement/Thrombosis
- Hypertension (Blood Pressure)
Self-Monitoring Product Segment Analysis
- Cholesterol Monitors
- Coagulation Monitoring
- Glucose Monitors
- Traditional Meters
- Continuous Monitors
- Noninvasive Glucose Monitors
- Combination Monitors
- Hypertension
- Potential/Emerging Self-Monitoring Segments
Market Factors
- Clinical Trial Issues
- Regulations and Guidance
- Managed care/Reimbursement
- Patient Compliance
- Sourcing/Private Labeling
Patient Self-Monitoring - Company Profile
For more information visit http://www.researchandmarkets.com/research/vn382p/patient
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Diagnostics